Awakn Life Sciences has announced that it has signed a five-year lease to open Awakn Clinics Trondheim.
The new clinic is part of the second stage of Awakn’s Nordic expansion plans. The development follows the company’s most recent announcement that it will be moving to a larger premises for its Oslo clinic.
Awakn’s CEO, Anthony Tennyson, commented: “There is real momentum growing for Awakn in Norway. In the space of a week to be able to share news of our move to a new, bigger premises in Oslo and an entirely new clinic in Trondheim is very exciting.
“For so many people who are suffering and in desperate need of a new more effective treatment, this will be great news for them.”
Awakn Clinics Trondheim will be a three-treatment room clinic spread over 1,400 square ft and will be situated in the centre of Trondheim, and clinic renovations will be finalised in late Q1 2023 with the opening expected soon after that.
Awakn’s Nordic expansion is being led by its Regional Director of the Nordics, Dr Lowan Stewart a renowned figure in the Nordic medical community. He was responsible for the adoption of ketamine therapy into the public healthcare system in Norway. The Trondheim clinic will be led by Dr Ingrid Casterberg, a prominent and well-respected psychiatrist in Norway.
Awakn also recently announced that it has entered into a new partnership agreement with Nushama, one of New York’s leading ketamine-assisted therapy centres. The agreement is with Nushama will bring Awakn’s Ketamine-assisted therapy treatment for alcohol-use disorder (AUD) to Nushama’s clinic in New York City.
